AdvisorShares Psychedelics ETF Rating $16.42 +0.92 (+5.94%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$16.37 -0.05 (-0.30%) As of 07/18/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.93Holdings in PSIL have an aggregate rating of Moderate Buy based on 95 analyst ratings issued in the past year covering 13 companies (74.2% of the portfolio).PSIL Aggregate Price Target$16.42High Prediction$16.42Average Prediction$16.42Low Prediction$16.42Holdings in PSIL have an aggregate price target of $16.42 and a range of $16.42 to $16.42 covering 13 companies (74.2% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy4 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 13 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.43%ATAIatai Life Sciences$3.23+15.8%3.2093 of 5 stars3.50$9.00 178.6%4High Trading Volume8.06%NRXPNRx Pharmaceuticals$2.94-3.0%2.5636 of 5 stars3.20$28.50 869.4%57.69%MNMDMind Medicine (MindMed)$8.882.1209 of 5 stars3.27$25.50 187.2%117.11%ALKSAlkermes$29.22-0.5%4.8084 of 5 stars2.83$40.92 40.0%12News CoverageAnalyst Forecast7.00%SAGESage Therapeutics$9.11-0.3%3.3598 of 5 stars1.94$8.75 -4.0%175.86%CMPSCOMPASS Pathways$4.30+10.8%1.8298 of 5 stars2.86$17.00 295.3%7Analyst ForecastAnalyst RevisionHigh Trading Volume5.67%GHRSGH Research$17.57+1.9%2.0603 of 5 stars3.00$32.00 82.1%7Analyst Revision5.67%NBIXNeurocrine Biosciences$132.02-1.6%4.4722 of 5 stars2.87$163.91 24.2%23Trending NewsAnalyst Revision5.01%STIMNeuronetics$3.66-4.4%1.8146 of 5 stars2.67$5.50 50.3%34.60%NEUPNeuphoria Therapeutics$7.45-0.5%1.887 of 5 stars3.00$21.00 181.9%1News Coverage4.60%VTGNVistaGen Therapeutics$2.55+0.4%0.5031 of 5 stars3.001Positive News2.21%RLMDRelmada Therapeutics$0.58-3.0%4.7492 of 5 stars2.25$5.00 766.6%41.27%ENVBEnveric Biosciences$1.32+3.1%1.9039 of 5 stars3.00$10.00 657.6%1 This page (NYSEARCA:PSIL) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
